Nakatsumi, H., Harada, K., Yuki, S., Ishiguro, A., Sawada, K., Sogabe, S., Ando, T., Sasaki, Y., Yoshikawa, A., Nakamura, M., Dazai, M., Tateyama, M., Muto, O., Kotaka, M., Sagawa, T., Muranaka, T., Hatanaka, K., Takagi, R., Sakata, Y., Komatsu, Y. (2025). A multicenter, prospective phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to anti-EGFR agents (HGCSG1801): Updated analyses.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.147